7th Annual Pharmacovigilance Asia 2016
The 7th Annual Pharmacovigilance Asia Summit once again gathers global and regional regulators together with industry experts to tackle the latest challenges in proactively building and managing a risk-management programme. What are the new quantitative methods in benefit-risk evaluation? How do you create a PV-focused culture and what is the role of the QPPV in Asia? How has digital health initiatives had an impact on the cost and accuracy of PV? How do you leverage on mobile applications to enhance medication adherence and patient support compliance?
We’ll be answering these questions and more as we bring together experts from Europe and APAC.
Key Topics To Be Addressed in 2016 Include:
The latest PV legislation – how will developments in US and Europe affect Asia?
Leveraging digital health applications to enhance patient support through detecting and managing safety signals and enhance patient support
Pro-actively negotiating risk management plans and benefit-risk evaluation in Asia – both quantitative and qualitative approaches
Creating a PV-focused culture and ensuring quality assurance across people, process and technologies
Ensuring continuity and compliance in MandA environment
How to effectively communicate risk through education, awareness, and collaboration with the community
For more information please email firstname.lastname@example.org or call +65 6722 9388
Booking : http://atnd.it/56293-1
Brochure : http://atnd.it/56293-2
Standard - SGD 3299,
Early Bird Pricing - SGD 2899
Category : Conferences | Science, Health and Medicine | Pharmaceuticals | Regulatory Affairs